Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 342.00
-1.00 (-0.29%)
Jul 16, 2026, 11:29 AM JST
Kringle Pharma Market Cap
Kringle Pharma has a market cap or net worth of 2.54 billion as of July 15, 2026. Its market cap has decreased by -58.50% in one year.
Market Cap
2.54B
Enterprise Value
948.49M
Revenue
73.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
342.00
Market Cap Chart
Since December 28, 2020, Kringle Pharma's market cap has decreased from 5.09B to 2.54B, a decrease of -50.13%. That is a compound annual growth rate of -11.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 2.54B | -10.21% |
| Dec 30, 2025 | 2.82B | -52.49% |
| Dec 30, 2024 | 5.95B | 30.66% |
| Dec 29, 2023 | 4.55B | 47.85% |
| Dec 30, 2022 | 3.08B | -0.04% |
| Dec 30, 2021 | 3.08B | -45.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PRISM BioLab Co.,LTD | 5.69B |
| Chiome Bioscience | 5.66B |
| Soiken Holdings | 5.60B |
| D. Western Therapeutics Institute | 4.77B |
| TMS Co., Ltd. | 4.69B |
| Kohjin Bio | 4.49B |
| Ribomic | 3.97B |
| Transgenic Group | 3.75B |